Stella Xu
Patrimonio netto: 486 392 $ in data 31/08/2026
Patrimonio netto: 486 392 $ in data 31/08/2026
Stella Xu is currently Managing Director at Quan Capital Management LLC since 2017.
Dr. Xu is Director at Walking Fish Therapeutics, Inc. since 2019.
Dr. Xu is Director at Zidan Medical, Inc. since 2018.
Dr. Xu is Director at Therorna, Inc. Former positions include Director at TempestTx, Inc., Director at ARMO Biosciences, Inc. from 2017 to 2018, Independent Director at NextCure, Inc. from 2018 to 2021, Director at Centrexion Therapeutics Corp.
from 2018 to 2022, Director at Tempest Therapeutics, Inc. from 2018 to 2022, Independent Director at Design Therapeutics, Inc. from 2020 to 2024, and Vice President, Site Head-R&D Center China at Roche Innovation Center from 2012 to 2017.
Education includes undergraduate degree from Peking University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2025 | 1.683 ( 0,03% ) | 486 392 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HBM HEALTHCARE INVESTMENTS AG | Direttore/Membro del Consiglio | 01/06/2020 |
Quan Capital Management LLC
Quan Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 01/08/2017 |
Zidan Medical, Inc.
Zidan Medical, Inc. Medical SpecialtiesHealth Technology Develops endobronchial radiofrequency ablation devices for treatment of lung cancer | Direttore/Membro del Consiglio | 01/11/2018 |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Direttore/Membro del Consiglio | 01/06/2019 |
Therorna, Inc. | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 13/06/2024 |
| TEMPEST THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 05/01/2022 |
| CENTREXION THERAPEUTICS CORPORATION | Direttore/Membro del Consiglio | 01/01/2022 |
| NEXTCURE, INC. | Direttore/Membro del Consiglio | 30/09/2021 |
| ░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Centrexion Therapeutics Corp.
Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for chronic pain and autoimmune disease | Health Technology |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Quan Capital Management LLC
Quan Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Design Therapeutics, Inc.
Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Roche Innovation Center | |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
Zidan Medical, Inc.
Zidan Medical, Inc. Medical SpecialtiesHealth Technology Develops endobronchial radiofrequency ablation devices for treatment of lung cancer | Health Technology |
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Therorna, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale